15100338

Source:http://linkedlifedata.com/resource/pubmed/id/15100338

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0010181, umls-concept:C0016538, umls-concept:C0021344, umls-concept:C0042210, umls-concept:C0205210, umls-concept:C0814225
pubmed:issue	8
pubmed:dateCreated	2004-4-21
pubmed:abstractText	Human papillomavirus (HPV) vaccine may be commercially available in a few years. We explored the clinical benefits and cost-effectiveness of introducing an HPV16/18 vaccine in a population with an organized cervical cancer screening program.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/R01-CA93435
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7503089
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Papillomavirus Vaccines, http://linkedlifedata.com/resource/pubmed/chemical/Viral Vaccines
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1460-2105
pubmed:author	pubmed-author:BoschF XavierFX, pubmed-author:FrancoEduardoE, pubmed-author:GoldieSue JSJ, pubmed-author:GrimaDanielD, pubmed-author:KohliMicheleM, pubmed-author:WeinsteinMilton CMC, pubmed-author:WrightThomas CTC
pubmed:issnType	Electronic
pubmed:day	21
pubmed:volume	96
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	604-15
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:15100338-Adult, pubmed-meshheading:15100338-Aged, pubmed-meshheading:15100338-Computer Simulation, pubmed-meshheading:15100338-Cost-Benefit Analysis, pubmed-meshheading:15100338-Decision Support Techniques, pubmed-meshheading:15100338-Female, pubmed-meshheading:15100338-Humans, pubmed-meshheading:15100338-Incidence, pubmed-meshheading:15100338-Markov Chains, pubmed-meshheading:15100338-Mass Screening, pubmed-meshheading:15100338-Middle Aged, pubmed-meshheading:15100338-Papillomaviridae, pubmed-meshheading:15100338-Papillomavirus Infections, pubmed-meshheading:15100338-Papillomavirus Vaccines, pubmed-meshheading:15100338-Tumor Virus Infections, pubmed-meshheading:15100338-United States, pubmed-meshheading:15100338-Uterine Cervical Neoplasms, pubmed-meshheading:15100338-Viral Vaccines
pubmed:year	2004
pubmed:articleTitle	Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine.
pubmed:affiliation	Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115-5924, USA. sgoldie@hsph.harvard.edu
pubmed:publicationType	Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't